HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael L West Selected Research

Bioreactors (Bioreactor)

12/2021The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael L West Research Topics

Disease

20Fabry Disease (Fabry's Disease)
12/2021 - 01/2002
4Chronic Renal Insufficiency
01/2020 - 04/2006
3Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 01/2002
3Heart Failure
11/2018 - 03/2011
2Cardiomyopathies (Cardiomyopathy)
01/2022 - 01/2020
2Disease Progression
12/2021 - 11/2018
2Inborn Genetic Diseases (Disease, Hereditary)
09/2021 - 03/2011
2Neuralgia (Stump Neuralgia)
10/2020 - 11/2010
2Pain (Aches)
10/2020 - 11/2010
1Pulmonary Hypertension
01/2021
1Congenital Abnormalities (Deformity)
01/2021
1Nephrocalcinosis
01/2021
1Nephrolithiasis
01/2021
1Primary hyperoxaluria type 1
01/2021
1Angiokeratoma
10/2020
1Cardiomegaly (Heart Hypertrophy)
01/2020
1Hypercalcemia (Milk Alkali Syndrome)
01/2020
1Hyperparathyroidism
01/2020
1Hypothyroidism
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Urinary Tract Infections (Urinary Tract Infection)
01/2020
1Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
01/2020
1Relapsing-Remitting Multiple Sclerosis
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Inflammation (Inflammations)
11/2018
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
11/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Phenylketonurias (Phenylketonuria)
01/2017
1Cysts
02/2015
1Myocardial Infarction
03/2011
1Diabetes Mellitus
04/2006
1Kidney Diseases (Kidney Disease)
04/2006

Drug/Important Bio-Agent (IBA)

6GalactosidasesIBA
09/2021 - 11/2010
5alpha-Galactosidase (Beano)IBA
12/2021 - 01/2002
4agalsidase alfaIBA
01/2022 - 08/2007
4EnzymesIBA
01/2021 - 03/2008
4Biomarkers (Surrogate Marker)IBA
11/2018 - 12/2010
3GlycosphingolipidsIBA
09/2021 - 12/2010
3CreatinineIBA
10/2020 - 03/2008
3globotriaosylceramide (globotriosylceramide)IBA
01/2017 - 03/2008
2agalsidase betaFDA Link
01/2020 - 01/2018
1Calcium OxalateIBA
01/2021
1lumasiranIBA
01/2021
1AlbuminsIBA
10/2020
1TroponinIBA
10/2020
1DenosumabFDA Link
01/2020
1antiglomerular basement membrane antibodyIBA
01/2020
1Alemtuzumab (Campath)FDA Link
01/2020
1Monoclonal AntibodiesIBA
01/2020
1Parathyroid Hormone (Parathormone)IBA
01/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2018
1Galectin 3 (LGALS3)IBA
11/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2018
1Galectin 1 (LGALS1)IBA
11/2018
1Atrial Natriuretic Factor (ANF)IBA
11/2018
1Interleukin-6 (Interleukin 6)IBA
11/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2018
1Matrix Metalloproteinases (MMPs)IBA
11/2018
1Lysergic Acid Diethylamide (LSD)IBA
06/2017
1Nitric Oxide Synthase (NO Synthase)IBA
01/2017
1sapropterin (tetrahydrobiopterin)FDA Link
01/2017
1AntioxidantsIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
02/2015
1globotriaosyl lysosphingolipidIBA
12/2010
1LipidsIBA
03/2008

Therapy/Procedure

9Enzyme Replacement Therapy
01/2022 - 01/2002
7Therapeutics
09/2021 - 04/2006
1Bioreactors (Bioreactor)
12/2021
1Organ Transplantation
01/2021
1Transplantation
01/2021
1Renal Dialysis (Hemodialysis)
01/2020
1Peritoneal Dialysis
01/2020